
BioTrace Medical
BioTrace Medical, Inc is dedicated to reinventing temporary pacing to improve patient outcomes and reduce hospital costs.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
N/A | $10.9m | Early VC | |
Total Funding | 000k |
Related Content
BioTrace Medical Inc. specializes in the development and commercialization of advanced temporary cardiac pacing leads. The company's flagship product, the Tempo Lead, is the only active fixation temporary pacing lead available in the United States, designed to improve patient outcomes during cardiac procedures. BioTrace Medical serves healthcare providers, including hospitals and cardiology clinics, operating within the medical device market. The business model revolves around the sale of its proprietary medical devices to these institutions, generating revenue through direct sales and distribution partnerships. The company is headquartered in Menlo Park, California, and is committed to innovation and excellence in cardiac care.
Keywords: cardiac pacing, temporary leads, active fixation, medical devices, healthcare providers, cardiology, patient outcomes, innovation, Menlo Park, Tempo Lead.